Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study

Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study

The Mexican influenza vaccination program does not include a recommendation for people aged 50–59 years without risk factors for influenza complications, and there are limited data regarding the cost-effectiveness of vaccinating this population. To explore the clinical and economic effects of includ...

Full description

Bibliographic Details
Main Authors: Miguel Betancourt-Cravioto, Jorge Abelardo Falcón-Lezama, Rodrigo Saucedo-Martínez, Myrna María Alfaro-Cortés, Roberto Tapia-Conyer
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Vaccines
Subjects:
influenza
vaccination
adult-aged population
cost effectiveness
Mexico
burden of disease
Online Access:https://www.mdpi.com/2076-393X/9/3/188

Similar Items

Similar Items